Mar 17, 2026
A new digital card platform offers a unified alternative to fragmented manufacturer programs, giving employers control over the budget, behavior and biology of obesity care.
Dec 01, 2025
A state public health insurance trust has selected Digbi Health to manage obesity treatment costs for its municipal and teachers union workers amid rising GLP-1 drug expenses.
Nov 18, 2025
The first precision biology-based telehealth service designed to improve GLP-1 tolerability, safety and effectiveness is now available as a self-pay option within employer populations.
Jan 17, 2025
GLP Compass now incorporates gut microbiome and genetic biomarkers that determine the tolerability and efficacy of GLP-1 drugs.
Sep 24, 2024
The program combines genetic insights, gut microbiome analysis and continuous glucose monitoring to improve GLP-1 outcomes and support successful medication tapering.
Sep 28, 2023
The program identifies an individual's best obesity treatment path with 87% accuracy — precision nutrition alone, nutrition with lower-cost medication, or nutrition with GLP-1 therapy.
Newswire by Digbi is Digbi Health's own newsroom. Releases published here are issued directly by Digbi Health and are not distributed by, or affiliated with, any third-party wire service.